Antibiotics

It is an anti-tumor antibiotic produced by Penicillum sp.AJ 117292.

It is an anti-tumor antibiotic produced by Penicillum sp.AJ 117292.

FCE 21424 is produced by the strain of Streptomyces peucetius. Its IC50 inhibitory effect on HeLa and P388 cells was less than that of dunomycin, and its anti-P388 effect was stronger than that of dunomycin in vivo.

FCE 24366 is produced by the strain of Streptomyces peucetius. Its IC50 inhibitory effect on HeLa and P388 cells was less than that of dunomycin, and its anti-P388 effect was stronger than that of dunomycin in vivo.

FCE 24367 is produced by the strain of Streptomyces peucetius. Its IC50 inhibitory effect on HeLa and P388 cells was less than that of dunomycin, and its anti-P388 effect was stronger than that of dunomycin in vivo.

FD-594 is produced by the strain of Streptomyces sp. TA-0256. It showed similar or slightly weaker cytotoxicity to adriamycin against HL-60, P388, L1210, HeLa and A549 cells, and moderate antibacterial activity against Gram-positive bacteria.

FD-891 is originally isolated from Streptomyces graminofaciiens A-8890. Its killing activity against human and mouse leukemia cells was 2 to 7 times stronger than that of Doxorubicin, and it also had the activity against Sake yeast.

It is originally isolated from FD-892. FD-892 has anti-tumor and anti-sake yeast activity, but the activity is weak.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. Saframycin A also has weak activity against gram-negative bacteria and mycobacteria. It has the effect of inhibiting mouse lymphocyte L-1210 with ID50 of 0.0056 μmol/L.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It also has weak activity against mycobacteria.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It also has weak activity against mycobacteria.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It also has weak activity against mycobacteria.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It has the effect of inhibiting mouse lymphocyte L-1210 with ID50 of 0.59 μmol/L.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It has the effect of inhibiting mouse lymphocyte L-1210 with ID50 of 0.03 μmol/L.

It is produced by the strain of Str. lavendulae No 314. It has the effect of anti-Gram-positive bacteria, and Saframycin A has the strongest antibacterial activity. It has the effect of inhibiting mouse lymphocyte L-1210 with ID50 of 0.033 μmol/L.

It is produced by the strain of Myxococcus xanthus. It has anti-gram-positive bacteria and gram-negative bacteria effects.

It is produced by the strain of Myxococcus xanthus. It has anti-gram-positive bacteria and gram-negative bacteria effects.

It is a benzoquinone antibiotic produced by the strain of Nocardia sp. M-53. It has activity against gram-positive bacteria and mycobacteria. In vivo, 10 mg/kg of Sakyomicin A had no effect against sarcoma 180A and leukemia P338 cells.

It is a Benzoquinone antibiotic produced by the strain of Nocardia sp. M-53. It has activity against gram-positive bacteria and mycobacteria.